Genetic diseases frontotemporal dementia

Wilcock DM, Colton CA (2008) Anti-amyloid-beta immunotherapy in Alzheimer s disease relevance of transgenic mouse studies to clinical trials. J Alzheimers Dis 15 555-569 Wilhamson J, LaRusse S (2004) Genetics and genetic counseling recommendations for Alzheimer s disease, frontotemporal dementia, and Creutzfeldt-Jakob disease. Curr Neurol... 

Watts GD, Wymer J, Kovach Ml et al. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36, 377-381. 

Kimonis V, Donkervoort S, Watts G. (2011) Inclusion Body Myopathy Associated with Paget Disease of Bone and/or Frontotemporal Dementia Gene GeneT-ests (wwwgenetestsorg) and University of Washington, Seattle. 

Kovach Ml, Waggoner B, Leal SM et al. (2001) Clinical debneation and localization to chromosome 9pl3.3-pl2 of a unique dominant disorder in four families hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 74(4), 458-475. 

Kumar KR, Needham M, Mina K, Davis M, Brewer J, Staples C, NgK, Sue CM, Mastaglia FL. Two Australian families with inclusion-body myopathy, Paget s disease of bone and frontotemporal dementia novel clinical and genetic findings. Neuromuscul Disord. 2010.20 330-4. 

Viassolo V, Previtah SC, Schiatti E et al. (2008) Inclusion body myopathy, Paget s disease of the bone and frontotemporal dementia recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling. Clin Genet 74, 54-60. 

---